Viewing Study NCT00470093


Ignite Creation Date: 2025-12-25 @ 1:19 AM
Ignite Modification Date: 2026-02-03 @ 3:44 AM
Study NCT ID: NCT00470093
Status: TERMINATED
Last Update Posted: 2018-11-16
First Post: 2007-05-03
Is NOT Gene Therapy: True
Has Adverse Events: True

Brief Title: Interferon Alfa and Interleukin-6 in Treating Patients With Recurrent Multiple Myeloma
Sponsor: Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
Organization:

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Multiple Myeloma and Plasma Cell Neoplasm View
Keywords:

Keywords

Keyword Brief Keyword Text View
None refractory multiple myeloma View
None stage I multiple myeloma View
None stage II multiple myeloma View
None stage III multiple myeloma View